| Page 94 | Kisaco Research

The future of payment integrity lies in the ability to harness Artificial Intelligence (AI) and Generative AI (GenAI) to improve outcomes. Yet, achieving measurable success requires more than just adopting technology—it demands the ability to set, track, and optimize benchmarks that align with your organization’s goals.

This session will dive into how healthcare payer executives can establish meaningful benchmarks to evaluate the impact of AI and GenAI on payment integrity. Learn how to define key performance indicators (KPIs) for fraud detection, cost savings, compliance improvements, and operational efficiencies. Explore strategies for tracking progress, identifying opportunities for refinement, and ensuring that your AI initiatives consistently deliver high-value results.

With a focus on real-world use cases and data-driven insights, attendees will walk away with actionable steps to enhance payment integrity outcomes through benchmark-driven approaches. Join us to discover how setting the right standards can help your organization maximize the potential of AI and GenAI, driving stronger financial and compliance performance.

Author:

Musheer Ahmed, PhD

CEO & Founder
Codoxo

Dr. Ahmed is the CEO and Founder of Codoxo. He founded Codoxo (formerly named FraudScope) to help make our healthcare system more affordable and effective. Codoxo’s Unified Cost Containment Platform uses AI to identify inaccurate payments earlier than traditional techniques, which helps ensure our scarce healthcare dollars go to real patient care. Dr. Ahmed developed this technology as a part of his Ph.D. dissertation at the Georgia Institute of Technology. A report by the JASON advisory group, the prestigious scientific advisory panel to the US government, reinforced that his doctoral research tackled some of the biggest challenges within the emerging health data infrastructure in the United States. Dr. Ahmed was honored to be included in the 40 Under 40 lists by Georgia Tech and the Atlanta Business Chronicle. Several media outlets have interviewed Dr. Ahmed about his work in reducing healthcare fraud, waste, abuse, and error. When he’s not eliminating payment inaccuracies, you’ll find him volunteering for various causes and spending time with his family.

Musheer Ahmed, PhD

CEO & Founder
Codoxo

Dr. Ahmed is the CEO and Founder of Codoxo. He founded Codoxo (formerly named FraudScope) to help make our healthcare system more affordable and effective. Codoxo’s Unified Cost Containment Platform uses AI to identify inaccurate payments earlier than traditional techniques, which helps ensure our scarce healthcare dollars go to real patient care. Dr. Ahmed developed this technology as a part of his Ph.D. dissertation at the Georgia Institute of Technology. A report by the JASON advisory group, the prestigious scientific advisory panel to the US government, reinforced that his doctoral research tackled some of the biggest challenges within the emerging health data infrastructure in the United States. Dr. Ahmed was honored to be included in the 40 Under 40 lists by Georgia Tech and the Atlanta Business Chronicle. Several media outlets have interviewed Dr. Ahmed about his work in reducing healthcare fraud, waste, abuse, and error. When he’s not eliminating payment inaccuracies, you’ll find him volunteering for various causes and spending time with his family.

Author:

Ric Baron, PhD

VP of Artificial Intelligence
Codoxo

Dr. Ric Baron is a healthcare technology strategist, AI analytics leader, and product
architect with over 20 years of experience in healthtech and insurtech. As Vice President of AI at Codoxo, he drives AI innovation and strategy, leading the development of advanced solutions for detecting fraud, waste, and abuse in healthcare—working toward the mission of making healthcare more affordable and accessible.

Before joining Codoxo, Dr. Baron led computational healthcare research initiatives at world-renowned institutions, including the Howard Hughes Medical Institute, UC San Diego, and the Huntsman Cancer Institute at the University of Utah. He also served as a supercomputing advisor to The National Academies of Sciences, Engineering, and Medicine.

Dr. Baron has held senior leadership roles at companies such as Komodo Health, CVS Health, and Swiss Re, contributing his expertise in AI and data-driven healthcare solutions.


He earned his PhD in Computer-Aided Chemistry from ETH Zürich.

Ric Baron, PhD

VP of Artificial Intelligence
Codoxo

Dr. Ric Baron is a healthcare technology strategist, AI analytics leader, and product
architect with over 20 years of experience in healthtech and insurtech. As Vice President of AI at Codoxo, he drives AI innovation and strategy, leading the development of advanced solutions for detecting fraud, waste, and abuse in healthcare—working toward the mission of making healthcare more affordable and accessible.

Before joining Codoxo, Dr. Baron led computational healthcare research initiatives at world-renowned institutions, including the Howard Hughes Medical Institute, UC San Diego, and the Huntsman Cancer Institute at the University of Utah. He also served as a supercomputing advisor to The National Academies of Sciences, Engineering, and Medicine.

Dr. Baron has held senior leadership roles at companies such as Komodo Health, CVS Health, and Swiss Re, contributing his expertise in AI and data-driven healthcare solutions.


He earned his PhD in Computer-Aided Chemistry from ETH Zürich.

 

Ric Baron, PhD

VP of Artificial Intelligence
Codoxo

Dr. Ric Baron is a healthcare technology strategist, AI analytics leader, and product
architect with over 20 years of experience in healthtech and insurtech. As Vice President of AI at Codoxo, he drives AI innovation and strategy, leading the development of advanced solutions for detecting fraud, waste, and abuse in healthcare—working toward the mission of making healthcare more affordable and accessible.

Ric Baron, PhD

VP of Artificial Intelligence
Codoxo

Ric Baron, PhD

VP of Artificial Intelligence
Codoxo

Dr. Ric Baron is a healthcare technology strategist, AI analytics leader, and product
architect with over 20 years of experience in healthtech and insurtech. As Vice President of AI at Codoxo, he drives AI innovation and strategy, leading the development of advanced solutions for detecting fraud, waste, and abuse in healthcare—working toward the mission of making healthcare more affordable and accessible.

Before joining Codoxo, Dr. Baron led computational healthcare research initiatives at world-renowned institutions, including the Howard Hughes Medical Institute, UC San Diego, and the Huntsman Cancer Institute at the University of Utah. He also served as a supercomputing advisor to The National Academies of Sciences, Engineering, and Medicine.

Dr. Baron has held senior leadership roles at companies such as Komodo Health, CVS Health, and Swiss Re, contributing his expertise in AI and data-driven healthcare solutions.


He earned his PhD in Computer-Aided Chemistry from ETH Zürich.

 

Musheer Ahmed, PhD

CEO & Founder
Codoxo

Dr. Ahmed is the CEO and Founder of Codoxo. He founded Codoxo (formerly named FraudScope) to help make our healthcare system more affordable and effective. Codoxo’s Unified Cost Containment Platform uses AI to identify inaccurate payments earlier than traditional techniques, which helps ensure our scarce healthcare dollars go to real patient care. Dr. Ahmed developed this technology as a part of his Ph.D. dissertation at the Georgia Institute of Technology.

Musheer Ahmed, PhD

CEO & Founder
Codoxo

Musheer Ahmed, PhD

CEO & Founder
Codoxo

Dr. Ahmed is the CEO and Founder of Codoxo. He founded Codoxo (formerly named FraudScope) to help make our healthcare system more affordable and effective. Codoxo’s Unified Cost Containment Platform uses AI to identify inaccurate payments earlier than traditional techniques, which helps ensure our scarce healthcare dollars go to real patient care. Dr. Ahmed developed this technology as a part of his Ph.D. dissertation at the Georgia Institute of Technology. A report by the JASON advisory group, the prestigious scientific advisory panel to the US government, reinforced that his doctoral research tackled some of the biggest challenges within the emerging health data infrastructure in the United States. Dr. Ahmed was honored to be included in the 40 Under 40 lists by Georgia Tech and the Atlanta Business Chronicle. Several media outlets have interviewed Dr. Ahmed about his work in reducing healthcare fraud, waste, abuse, and error. When he’s not eliminating payment inaccuracies, you’ll find him volunteering for various causes and spending time with his family.

 

Ali Dalloul

Global CSO & CEO, US
G42

Ali is a seasoned technology executive with over 30 years of global tech and business leadership experience, currently serving as the G42.ai Global Chief Strategy Officer (CSO), and G42.ai USA CEO.

As G42.ai CSO, he is responsible for setting the global corporate strategy across our portfolio of companies and driving strategic growth and partnerships across industries globally.

Ali Dalloul

Global CSO & CEO, US
G42

Ali Dalloul

Global CSO & CEO, US
G42

Ali is a seasoned technology executive with over 30 years of global tech and business leadership experience, currently serving as the G42.ai Global Chief Strategy Officer (CSO), and G42.ai USA CEO.

As G42.ai CSO, he is responsible for setting the global corporate strategy across our portfolio of companies and driving strategic growth and partnerships across industries globally.

As G42.ai USA CEO, he is responsible for building out G42’s market expansion in the U.S. and expansion of the global Intelligence Grid working across our broad partner ecosystem, industries and developing vertical AI solutions.

Prior, he was the worldwide VP of Azure AI Customer Experience Engineering at Microsoft Corp, responsible for AI solutions engineering and GPT model customization, product adoption, business strategy, and product commercialization across Microsoft’s collective Azure AI Platform (Azure OpenAI, AI Services, Search, ML).

Ali’s leadership has been instrumental in scaling Microsoft’s AI business to billions of dollars in revenue, while driving adoption among marquee enterprise customers across industries worldwide, and leading strategic CEO/C-Suite engagements for AI transformation.

Ali served on the Board of the Linux Foundation AI & Data, where he helps shape the development of open-source AI and data policy and standards. In addition, he was a member of the Monetary Authority of Singapore (MAS) International Technology Advisory Panel (ITAP), offering strategic guidance on AI’s integration into fintech and capital markets responsibly.

Ali has held several leadership roles at Microsoft, including Vice President of Strategy & Commercialization for Azure AI, where he led market-making partnerships and global growth efforts, as well as leading the Ambient Intelligence initiatives, championing the Sharing Economy, and steering strategic business operations across Microsoft’s global divisions, helping shape the initial strategies that led to Microsoft’s acceleration of AI services into global products.

 

Frédéric Chevallier

Partner
Herbert Smith Freehills

Frédéric Chevallier

Partner
Herbert Smith Freehills

Frédéric Chevallier

Partner
Herbert Smith Freehills
2025 Sample Attendee List
 

Stefano Barone

Advisor AML, CTF
Global Initiative Against Transnational Organized Crime

Stefano Barone is an investigative professional with over 15 years of expertise in financial crime and compliance. As a Chief Investigator with the Guardia di Finanza, he led high-profile cases in VAT fraud, money laundering, and corruption, achieving significant asset recoveries. At the World Customs Organization, he spearheaded Project Tentacle, an AML/CTF initiative enhancing global cooperation against economic crime.

Stefano Barone

Advisor AML, CTF
Global Initiative Against Transnational Organized Crime

Stefano Barone

Advisor AML, CTF
Global Initiative Against Transnational Organized Crime

Stefano Barone is an investigative professional with over 15 years of expertise in financial crime and compliance. As a Chief Investigator with the Guardia di Finanza, he led high-profile cases in VAT fraud, money laundering, and corruption, achieving significant asset recoveries. At the World Customs Organization, he spearheaded Project Tentacle, an AML/CTF initiative enhancing global cooperation against economic crime.

Currently part of the GITOC expert network, Stefano focuses on AML, CFT, and organized crime. Previously at FIFA, he investigated misconduct and helped establish the first Integrity Task Force for the Qatar 2022 World Cup.

 

Harriet Lord

Director, Corporate Intelligence
S-RM

Harriet is a Director in S-RM's Corporate Intelligence division, based in London. She joined S-RM in 2017 as head of the Europe regional desk and, in 2020, took over responsibilities for the Corporate Intelligence research teams in EMEA, covering Europe, Russia and the CIS, the Middle East and North Africa, and Sub-Saharan Africa. S-RM’s Corporate Intelligence teams deploy their regional and industry-specific expertise to provide a range of due diligence and investigative services.

Harriet Lord

Director, Corporate Intelligence
S-RM

Harriet Lord

Director, Corporate Intelligence
S-RM

Harriet is a Director in S-RM's Corporate Intelligence division, based in London. She joined S-RM in 2017 as head of the Europe regional desk and, in 2020, took over responsibilities for the Corporate Intelligence research teams in EMEA, covering Europe, Russia and the CIS, the Middle East and North Africa, and Sub-Saharan Africa. S-RM’s Corporate Intelligence teams deploy their regional and industry-specific expertise to provide a range of due diligence and investigative services. From enhanced due diligence on potential clients, partners and third parties, to in-depth research into investment targets, new markets and regulatory environments, or investigations to support contentious situations, including litigation, arbitration and internal investigations, S-RM’s intelligence and analysis helps clients with a range of compliance, ESG and strategic questions.